Table 1.
Variables | Total |
---|---|
Gender (n = 2640) [n (%)] | |
Female | 1243 (47.1) |
Male | 1397 (52.9) |
Age (y, n = 2640) [median (IQR)] | 66.0 (52.0–76.7) |
BMI (kg/m2, n = 2512) [median (IQR)] | 25.4 (22.6–28.8) |
Native papilla (n = 2640) [n (%)] | |
Yes | 1491 (56.5) |
No | 1133 (42.9) |
Other (e.g., hepaticojejunostomy) | 16 (0.6) |
Previous EST (n = 2630) [n (%)] | |
No | 1591 (60.5) |
Biliary EST only | 774 (29.4) |
Pancreatic EST only | 147 (5.6) |
Biliary and pancreatic EST | 118 (4.5) |
Anesthetic technique (n = 2632) [n (%)] | |
Endoscopist-directed | 714 (27.1) |
Anesthesiologist-directed | 1918 (72.9) |
Indication (n = 3026) [n (%)] | |
CBD stone | 1084 (35.8) |
Biliary stricture | 818 (27.0) |
PSC | 321 (10.6) |
Post LCC | 116 (3.8) |
Post LTx | 84 (2.8) |
Chronic pancreatitis | 235 (7.8) |
Acute pancreatitis | 89 (2.9) |
Pseudocyst | 126 (4.2) |
Other | 153 (5.1) |
Total cannulation time (min, n = 756) [median (IQR)] | 1.08 (0.25–5.67) |
Types of interventions (n = 5519) [n (%)] | |
Biliary EST | 1387 (25.1) |
CBD stone extraction | 1033 (18.7) |
Biliary plastic stent placement, exchange, or removal | 800 (14.5) |
ERC cytology | 691 (12.5) |
Biliary dilatation | 407 (7.4) |
Metal stent placement | 359 (6.5) |
Pancreatic stent placement, exchange, or removal | 259 (4.7) |
Pancreatic EST | 190 (3.4) |
Pancreatic dilatation | 158 (2.9) |
ERP cytology | 62 (1.1) |
Pseudocystogastrostomy | 26 (0.5) |
Prophylactic pancreatic stent | 29 (0.6) |
Spyglass | 56 (1.0) |
Double-balloon ERCP | 62 (1.1) |
Total procedural time (min, n = 2555) [median (IQR)] | 22.0 (15.0–33.0) |
Operator of fluoroscopy equipment (n = 2640) [n (%)] | |
Endoscopist | 2195 (83.1) |
Radiographer | 445 (16.9) |
ERCP, endoscopic retrograde cholangiopancreatography; BMI, body mass index; EST, endoscopic sphincterotomy; CBD, common bile duct; PSC, primary sclerosing cholangitis; LCC, laparoscopic cholecystectomy; LTx, liver transplantation; IQR, interquartile range; ERC, endoscopic retrograde cholangiography; and ERP, endoscopic retrograde pancreatography.